• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$45.86 $0.94 (2.09%)

REAL-TIME: Last trade at

Jazz Pharmaceuticals, Inc.

NASDAQ:JAZZ

Jump to this page for:

Related Resources

Jazz Pharma (JAZZ): Compelling Specialty Pharma Stock Spearheaded By Xyrem

5/24/2012 by iStockAnalyst

A Forward Look, the Year Ahead - Featured Research on Jazz Pharmaceuticals and Human Genome Sciences

5/24/2012 by Marketwire

Top Analyst Upgrades & Downgrades (AMAT, ARBA, BX, CPLA, CHA, DELL, DNDN, EMC, FB, GMT, ICE, JAZZ, NDAQ, PCX, PG, SBUX, WY)

5/23/2012 by 24/7 Wall Street

UPDATE: Oppenheimer Starts Jazz Pharmaceuticals (JAZZ) at Outperform

5/23/2012 by StreetInsider.com

Jazz Pharmaceuticals initiated with an Outperform at Credit Suisse

5/23/2012 by Theflyonthewall.com

Jazz Pharmaceuticals initiated with an Outperform at Oppenheimer

5/22/2012 by Theflyonthewall.com

Jazz Pharmaceuticals management to meet with Jefferies

5/18/2012 by Theflyonthewall.com

NASDAQ Changes Up Biotech Index Members & Weightings

5/14/2012 by 24/7 Wall Street

NASDAQ Biotechnology Index - semi-annual changes

5/14/2012 by Theflyonthewall.com

Jazz Pharma Stock Drops Despite Strong Q1 Showing

5/9/2012 by Investor's Business Daily

Auriga Reiterates a 'Buy' on Jazz Pharmaceuticals (JAZZ); Lifting Numbers on 'Beat & Raise'

5/9/2012 by StreetInsider.com

Jazz Pharma Earnings Top Expectations; Guidance Up

5/8/2012 by Investor's Business Daily

Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results

5/8/2012 by Genetic Engineering News

Jazz Pharmaceuticals sees 2012 adjusted EPS $4.25-$4.40, consensus $4.45

5/8/2012 by Theflyonthewall.com

Jazz Pharmaceuticals reports Q1 adjusted EPS 91c, consensus 84c

5/8/2012 by Theflyonthewall.com

Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results

5/8/2012 by PR Newswire

Critical Alerts For Macy's, Avis, Rackspace, Stone Energy, and Jazz Pharmaceuticals Released By InvestorsObserver

5/7/2012 by StockWatch

Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012

4/30/2012 by StockWatch

Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012

4/30/2012 by PR Newswire

Highs & Lows: Aware, Jazz Pharmaceuticals, and InterMune

4/27/2012 by Schaeffer's Trading Floor Blog

Jazz Pharma And Expedia Stocks Are Surging, Allscripts, Deckers Outdoor And Digi Shares Are Plummeting

4/27/2012 by iStockAnalyst

Highs & Lows: Aware, Jazz Pharmaceuticals, and InterMune

4/27/2012 by Schaeffer's Investment Research

Amazon.com, Jazz Pharmaceuticals plc Among Stocks Gapping Up Friday

4/27/2012 by FOXBusiness.com

Amazon.com, Jazz Pharmaceuticals plc…

4/27/2012 by FOX - Fox 5 - Washington DC

Jazz Pharmaceuticals price target raised to $74 from $64 at Jefferies

4/27/2012 by Theflyonthewall.com

Jazz Pharmaceuticals gaps up, resistance is at $53.10, its life high

4/27/2012 by Theflyonthewall.com

Jefferies Boosts Numbers on Jazz Pharmaceuticals (JAZZ) Following Deal

4/27/2012 by StreetInsider.com

Jazz Pharma To Acquire EUSA For $650 Mln Plus Milestone Payment; Shares Rise

4/27/2012 by RTTNews

After-market Movers For April 26 (AMZN, EXPE, JAZZ, SBUX, MDRX, DECK, DGII)

4/26/2012 by RTTNews

Another Pharmaceutical Deal Goes Down

4/26/2012 by Deal Journal - The Wall Street Journal

Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma

4/26/2012 by PR Newswire

5 Biotech Stocks To Boost Your Portfolio Now

4/26/2012 by Seeking Alpha

Auriga Reiterates a 'Buy' on Jazz Pharmaceuticals (JAZZ) After Call With Patent Attorney

4/20/2012 by StreetInsider.com

Critical Alerts for Baidu, Philip Morris International, GlaxoSmithKline, Tata Motors, and Jazz Pharmaceuticals Released by Seven Summits Research

4/17/2012 by PR Newswire

Leerink Swann Starts Jazz Pharmaceuticals (JAZZ) at Outperform; Compelling Risk/Reward

4/13/2012 by StreetInsider.com

Jazz Pharmaceuticals initiated with an Outperform at Leerink

4/13/2012 by Theflyonthewall.com

5 Global Stock Buys and 2 Sells

4/12/2012 by InvestorPlace

Jazz retreats ahead of April 26 Markman hearing

4/11/2012 by Theflyonthewall.com

Jazz Pharmaceuticals drops 5%, or $2.47, to $46.41

4/11/2012 by Theflyonthewall.com

Citi Starts Jazz Pharmaceuticals (JAZZ) at Buy

4/10/2012 by StreetInsider.com
See More Articles...